gaap:InProcessResearchAndDevelopmentMember
pfe:BiopharmaSegmentMember
2024-09-30
2024-12-31
0000078003
pfe:DisitamabVedotinMember
us-gaap:InProcessResearchAndDevelopmentMember
pfe:BiopharmaSegmentMember
2024-01-01
2024-12-31
0000078003
pfe:OtherDevelopedTechnologyRightsInProcessResearchAndDevelopmentAndFiniteLivedLicensingAgreementMember
pfe:BiopharmaSegmentMember
2024-01-01
2024-12-31
0000078003
us-gaap:InProcessResearchAndDevelopmentMember
pfe:BiopharmaSegmentMember
2024-01-01
2024-12-31
0000078003
pfe:BiopharmaSegmentMember
2023-01-01
2023-12-31
0000078003
pfe:BiopharmaSegmentMember
2023-10-02
2023-12-31
0000078003
pfe:EtrasimodVelsipityMember
us-gaap:InProcessResearchAndDevelopmentMember
pfe:BiopharmaSegmentMember
2023-01-01
2023-12-31
0000078003
us-gaap:DevelopedTechnologyRightsMember
pfe:Prevnar13Member
pfe:BiopharmaSegmentMember
2023-01-01
2023-12-31
0000078003
pfe:OtherInProcessResearchAndDevelopmentAndDevelopedTechnologyRightsMember
pfe:BiopharmaSegmentMember
2023-01-01
2023-12-31
0000078003
us-gaap:InProcessResearchAndDevelopmentMember
pfe:BiopharmaSegmentMember
2023-01-01
2023-12-31
0000078003
us-gaap:InProcessResearchAndDevelopmentMember
pfe:BiopharmaSegmentMember
2022-01-01
2022-12-31
0000078003
us-gaap:DevelopedTechnologyRightsMember
pfe:BiopharmaSegmentMember
2022-01-01
2022-12-31
0000078003
pfe:HospiraMember
pfe:LicensingAgreementsAndOtherMember
pfe:GenericSterileInjectableProductMember
2022-01-01
2022-12-31
0000078003
2024-07-01
2024-09-29
0000078003
pfe:NimbusMember
2023-01-01
2023-12-31
0000078003
pfe:TransitionServiceAgreementMember
2022-01-01
2022-12-31
0000078003
pfe:ViiVMember
2022-01-01
2022-12-31
0000078003
us-gaap:InProcessResearchAndDevelopmentMember
2024-12-31
0000078003
us-gaap:FairValueInputsLevel1Member
us-gaap:InProcessResearchAndDevelopmentMember
2024-12-31
0000078003
us-gaap:FairValueInputsLevel2Member
us-gaap:InProcessResearchAndDevelopmentMember
2024-12-31
0000078003
us-gaap:FairValueInputsLevel3Member
us-gaap:InProcessResearchAndDevelopmentMember
2024-12-31
0000078003
us-gaap:InProcessResearchAndDevelopmentMember
2024-01-01
2024-12-31
0000078003
us-gaap:DevelopedTechnologyRightsMember
2024-12-31
0000078003
us-gaap:FairValueInputsLevel1Member
us-gaap:DevelopedTechnologyRightsMember
2024-12-31
0000078003
us-gaap:FairValueInputsLevel2Member
us-gaap:DevelopedTechnologyRightsMember
2024-12-31
0000078003
us-gaap:FairValueInputsLevel3Member
us-gaap:DevelopedTechnologyRightsMember
2024-12-31
0000078003
us-gaap:DevelopedTechnologyRightsMember
2024-01-01
2024-12-31
0000078003
pfe:BrandMember
2024-12-31
0000078003
us-gaap:FairValueInputsLevel1Member
pfe:BrandMember
2024-12-31
0000078003
us-gaap:FairValueInputsLevel2Member
pfe:BrandMember
2024-12-31
0000078003
us-gaap:FairValueInputsLevel3Member
pfe:BrandMember
2024-12-31
0000078003
pfe:BrandMember
2024-01-01
2024-12-31
0000078003
pfe:LicensingAgreementsAndOtherMember
2024-12-31
0000078003
us-gaap:FairValueInputsLevel1Member
pfe:LicensingAgreementsAndOtherMember